Your browser doesn't support javascript.
loading
Changes in the quality of cancer care as assessed through performance indicators during the first wave of the COVID-19 pandemic in 2020: a Scoping Review
Ana Sofia Carvalho; Oscar Brito Fernandes; Mats de Lange; Hester Lingsma; Niek Klazinga; Dionne Kringos.
Afiliação
  • Ana Sofia Carvalho; Erasmus University Rotterdam: Erasmus Universiteit Rotterdam
  • Oscar Brito Fernandes; University of Amsterdam: Universiteit van Amsterdam
  • Mats de Lange; University of Amsterdam: Universiteit van Amsterdam
  • Hester Lingsma; Erasmus University Rotterdam: Erasmus Universiteit Rotterdam
  • Niek Klazinga; University of Amsterdam: Universiteit van Amsterdam
  • Dionne Kringos; University of Amsterdam: Universiteit van Amsterdam
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-22271303
ABSTRACT
ObjectivesSummarize performance indicators used in the literature to evaluate the impact of the COVID-19 pandemic on cancer care (January-June 2020), and to assess changes in the quality of care as assessed via selected indicators. MethodsScoping review. Indicators and their reported trends were collated following the cancer care pathway. ResultsDatabase searches retrieved 6277 articles, 838 articles met the inclusion criteria, and 135 articles were included after full-text screening, from which 917 indicators were retrieved. Indicators assessing the diagnostic process showed a decreasing trend from 33 indicators reporting on screening, 30 (91%) signalled a decrease during the pandemic (n=30 indicators, 91%). A reduction was also observed in the number of diagnostic procedures (n=64, 58%) and in the diagnoses (n=130, 89%). The proportion of diagnoses in the emergency setting and waiting times showed an increasing trend (n=8, 89% and n=14, 56%, respectively). Nine indicators (64%) showed stability in cancer stages distribution. A decreasing trend in the proportion of earliest stage cancers was reported by 63% of indicators (n=9), and 70% (n=43) of indicators showed an increasing trend in the proportion of advanced-stage cancers. Indicators reflecting the treatment process signalled a reduction in the number of procedures 79% (n=82) of indicators concerning surgeries, 72% (n=41) of indicators assessing trends in radiotherapy, and 93% (n=40) of indicators related to systemic therapies. Modifications in cancer treatment were frequently reported 64% (n=195) of indicators revealed changes in treatment. Ten indicators (83%) signalled a decreasing number of hospital admissions. ConclusionHealth systems struggled to ensure continuity of cancer care. As this pandemic keeps evolving, the trends reported over the first 6 months of 2020 provide an argument to monitor these changes closely. This information needs to be transparent, standardised, and timely, allowing to monitor quality and outcomes of care during crises and inform policy responses.
Licença
cc_by
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Diagnostic_studies / Experimental_studies / Review Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Diagnostic_studies / Experimental_studies / Review Idioma: En Ano de publicação: 2022 Tipo de documento: Preprint